What is the current valuation of the US hemostats market in 2024?

The overall market valuation was $984.9 Million in 2024. Read More

What is the projected market valuation for the US hemostats market by 2035?

The projected valuation for 2035 is $1592.75 Million. Read More

What is the expected CAGR for the US hemostats market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 4.47%. Read More

Which companies are the key players in the US hemostats market?

Key players include Johnson & Johnson, Baxter International, Medtronic, Stryker Corporation, Terumo Corporation, B. Braun Melsungen AG, Hemostasis, Inc., and Z-Medica, LLC. Read More

What are the main types of hemostats in the US market and their valuations?

Main types include Thrombin-based Hemostats valued at $200.0 - $320.0 Million, Gelatin-based at $250.0 - $400.0 Million, and others. Read More

What applications drive the demand for hemostats in the US market?

Demand is driven by Surgical Procedures valued at $300.0 - $480.0 Million and Traumatic Injuries at $250.0 - $400.0 Million. Read More

What are the different formulations of hemostats available in the US market?

Formulations include Liquid valued at $300.0 - $480.0 Million and Ready-to-use at $250.0 - $400.0 Million. Read More

Which end-use segments are prominent in the US hemostats market?

Prominent end-use segments include Hospitals valued at $394.95 - $635.25 Million and Ambulatory Surgical Centers at $295.43 - $475.25 Million. Read More

How does the market for gelatin-based hemostats compare to other types?

Gelatin-based Hemostats are valued at $250.0 - $400.0 Million, indicating a strong position compared to other types. Read More

What is the potential growth outlook for the US hemostats market?

The market appears poised for growth, with a projected valuation increase to $1592.75 Million by 2035. Read More

US Hemostats Market

ID: MRFR/MED/15171-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Hemostats Market Research Report By Product Type (Thrombin-based Hemostats, Gelatin-based Hemostats, Collagen-based Hemostats, Cellulose-based Hemostats, Other Hemostatic Agents), By Application (Surgical Procedure, Traumatic Injury, Dental Procedure, Obstetrics and Gynecology, Other Applications), By Formulation (Lyophilized Powder, Liquid, Ready-to-use, Foam, Other Formulations) and By End Use (Hospitals, Ambulatory Surgical Centers, Research Laboratories, Military Institutions) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Type (USD Million)
  1. 4.1.1 Thrombin-based Hemostats
  2. 4.1.2 Gelatin-based Hemostats
  3. 4.1.3 Collagen-based Hemostats
  4. 4.1.4 Cellulose-based Hemostats
  5. 4.1.5 Other Hemostatic Agents
2. 4.2 Food, Beverages & Nutrition, BY Application (USD Million)
  1. 4.2.1 Surgical Procedures
  2. 4.2.2 Traumatic Injuries
  3. 4.2.3 Dental Procedures
  4. 4.2.4 Obstetrics and Gynecology
  5. 4.2.5 Other Applications
3. 4.3 Food, Beverages & Nutrition, BY Formulation (USD Million)
  1. 4.3.1 Lyophilized Powder
  2. 4.3.2 Liquid
  3. 4.3.3 Ready-to-use
  4. 4.3.4 Foam
  5. 4.3.5 Other Formulations
4. 4.4 Food, Beverages & Nutrition, BY End Use (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Ambulatory Surgical Centers
  3. 4.4.3 Research Laboratories
  4. 4.4.4 Military Institutions
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Johnson & Johnson (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Baxter International (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Medtronic (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Stryker Corporation (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Terumo Corporation (JP)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 B. Braun Melsungen AG (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Hemostasis, Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Z-Medica, LLC (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY FORMULATION
5. 6.5 US MARKET ANALYSIS BY END USE
6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 (% SHARE)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 (% SHARE)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY FORMULATION, 2024 (% SHARE)
17. 6.17 FOOD, BEVERAGES & NUTRITION, BY FORMULATION, 2024 TO 2035 (USD Million)
18. 6.18 FOOD, BEVERAGES & NUTRITION, BY END USE, 2024 (% SHARE)
19. 6.19 FOOD, BEVERAGES & NUTRITION, BY END USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY FORMULATION, 2025-2035 (USD Million)
  4. 7.2.4 BY END USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Type (USD Million, 2025-2035)

Thrombin-based Hemostats
Gelatin-based Hemostats
Collagen-based Hemostats
Cellulose-based Hemostats
Other Hemostatic Agents

Food, Beverages & Nutrition By Application (USD Million, 2025-2035)

Surgical Procedures
Traumatic Injuries
Dental Procedures
Obstetrics and Gynecology
Other Applications

Food, Beverages & Nutrition By Formulation (USD Million, 2025-2035)

Lyophilized Powder
Liquid
Ready-to-use
Foam
Other Formulations

Food, Beverages & Nutrition By End Use (USD Million, 2025-2035)

Hospitals
Ambulatory Surgical Centers
Research Laboratories
Military Institutions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”